Featured essay
Fill-finish outsourcing: CDMOs meet soaring demand for high-quality servicesModern Catalyst The fill-finish pharmaceutical landscape is undergoing a structural shift driven by three converging forces: explosive demand for injectable and biologic therapies, the capital and regulatory burden of sterile manufacturing, and the emergence of AI-powered…
Read full essay